Two ME/CFS, yes, ME/CFS low dose naltrexone papers appear, one fibromyalgia report attempts to turn dosing protocols on their head, one patient blows through normal dose levels with spectacular success, Jarred Younger hunts for a more powerful naltrexone, and then...
It must have seemed like a done deal. Daiichi Sankyo was so confident that its safer, more effective version of Lyrica (pregabalin) called Mirogabalin was going to beat the pants off the best-selling drug for FM. How confident were they? They funded easily the largest...
It was a project birthed in hope. Pal Schaathun, a Norwegian filmmaker would document what he hoped might be the end of chronic fatigue syndrome (ME/CFS). That, unfortunately, turned out not to be but Schaathun ended up documenting – in strikingly beautiful...
I was a bit anxious as I waited for Dr. Pridgen to pick up. It had been a year and a half since we talked and I had heard nothing. Given Pridgen’s approach – using antivirals in a disease (fibromyalgia) that few connected with pathogens – his...
A recent Australian study suggested an already FDA approved drug can revive the not so killer natural killer cells found in ME/CFS in the lab. If that finding translates to humans we’ll have a breakthrough in the one verified immune hole in ME/CFS – one...
What do a vaccine, a cough suppressant, a drug with only numbers for a name, an anesthetic, and the new migraine drugs have in common? They’re all either being tested in an FM clinical trial or are about to be. FM may not be getting a lot of research but...
